Latest Expansion News

Alvo Minerals has expanded its Bluebush heavy rare earth project in Brazil, with new ground, encouraging clay intercepts and Florence drilling advancing toward a maiden resource. But quarter-end cash of A$227,000 covered only 0.28 quarters of reported outgoings before a subsequent A$1 million placement and option exercises.

Aldoro Resources has increased its Kameelburg Mineral Resource by 35% to 804.5 million tonnes, including a maiden 162.1Mt Indicated category. The Namibia project is now moving towards development studies, backed by A$4.3 million in convertible notes but still carrying substantial geological and funding risks.

Osteopore reported record quarterly revenue of A$859,000 in Q3 CY26 as it added market access in Thailand and Saudi Arabia and completed its first customised Hainan implant. The regenerative implant maker remains cash-flow negative, with A$712,000 in cash and A$14 million still available under its convertible note facility.

Admiralty Resources increased quarterly iron ore concentrate production at its Mariposa project by 32% to 41,792 tonnes, even as adverse weather suspended mining. The result relied on stockpiled ore while the processing plant remained in commissioning and the company carried A$9.66 million of drawn debt facilities.

Zimplats will replace long-serving chief executive Alexander Mhembere with internal successor Dr Stanley Segula from 1 November. The handover preserves operational continuity while Mhembere remains chairman of the company’s Zimbabwean operating subsidiary.

Palisade Metals has expanded its Finley Basin tungsten project and moved closer to maiden drilling in Montana, but ended September with A$1.46 million in cash and estimated funding for only 0.79 quarters. The company is considering asset sales and equity funding alternatives as it advances its North American critical minerals strategy.

Barys Resources has added a 110.8-square-kilometre gold exploration licence in Kazakhstan, taking its North Balkhash portfolio to 445.8 square kilometres. The expansion comes with a sharper funding constraint: cash fell to A$1.039 million at quarter-end, equivalent to about one quarter of funding at the reported spending rate.

WhiteHawk reported a US$313,000 operating cash outflow for the September quarter, while a new A$1.5 million debt facility and A$1.24 million in annualised cost savings support its next phase. The post-quarter completion of Quixxi adds AI governance products, international customers and a four-year A$635,238 Italian contract, but revenue conversion remains the test.

Alpha HPA has moved closer to commissioning its flagship Stage 2 facility, with permanent plant energisation targeted for December while Stage 1 customer demand continues to outstrip available capacity. The company also began drawing funds from a $160 million government-backed commitment and reported $81.4 million in cash at quarter-end.

Adherium delivered a fifth consecutive quarterly record for remote patient monitoring revenue, but ended September with only A$120,000 in cash after a A$3.499 million operating outflow. Post-quarter loans and an AstraZeneca milestone payment have improved near-term liquidity, although further funding remains central to the company’s plans.

HALO Technologies reported a 21% quarterly revenue decline as weaker brokerage activity outweighed growth in subscriptions. A $5.34 million convertible note issue lifted cash to $3.07 million, but the company still reported a net operating cash outflow of $1.47 million.

Vita Resources ended the September quarter with just A$77,000 in cash, equivalent to an estimated 0.2 quarters of funding, even as it expands Ninnis exploration and pursues new gold opportunities in New Zealand. The company is seeking up to A$500,000 through a non-underwritten share purchase plan while key exploration milestones remain ahead.